
8.89 Delayed Data As of May 17 | ![]() Today’s Change | 7.26 Today|||52-Week Range 54.74 | -73.94% Year-to-Date |
The 11 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 19.00, with a high estimate of 26.00 and a low estimate of 12.00. The median estimate represents a +113.72% increase from the last price of 8.89.
The current consensus among 12 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.